Form D · Biotechnology
SIRONA BIOCHEM CORP
Vancouver, A1 · CIK 0001572578
Offering snapshot reported Mar 20, 2013 · SEC filing
- Reported sold
- $24.3K Offering amount: $60.7K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 5, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 20, 2013 | Initial | $24,295 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-193644
13(a) represents the price of the units (250,000 units @ C$0.10), plus the aggregate price of the warrants forming part of the units (250,000 warrants @ C$0.15), converted to US$. There is no guarantee the warrants will be exercised.
Source: Form D, filed Mar 20, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neil Belenkie | Director, Executive |
| Geraldine Deliencourt Godefroy | Director, Executive |
| Christopher Hopton | Director, Executive |
| Alex Sandro Marazzi | Director |
| Michael Rogers | Director |
| Howard J Verrico | Director, Executive |
| Chris Verrico | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
955 789 West Pender Street
Vancouver, A1, V6C 1H2
Vancouver, A1, V6C 1H2